CD80 and neoplasm: Further, miR-125b inhibits M2 polarization through the repression of IRF4 and, when overexpressed in macrophages, increases in vitro CD8+ T-cell priming, tumor clearance, and CD80/86, CD40, MHCII, and IFN-γ receptor (IFN-γR) expression (160).